• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去风险营养状态的胃癌患者,肌肉减少症对根治性胃切除术后临床结局的影响。

Impact of sarcopenia on clinical outcomes after radical gastrectomy for patients without nutritional risk.

机构信息

Department of Gastrointestinal Surgery, Shanghai Tenth People's Hospital Affiliated to Tongji University, Shanghai, China.

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.

出版信息

Nutrition. 2019 May;61:61-66. doi: 10.1016/j.nut.2018.10.025. Epub 2018 Oct 24.

DOI:10.1016/j.nut.2018.10.025
PMID:30703570
Abstract

OBJECTIVE

The aim of this study was to investigate the prevalence of sarcopenia in patients without nutritional risk and the association between sarcopenia and postoperative outcomes after radical gastrectomy in these patients.

METHOD

We conducted a study of non-nutritional risk patients with gastric cancer who underwent gastrectomy from August 2014 to December 2017 in two centers. Nutritional Risk Screening 2002 (NRS 2002) was used to evaluate the nutritional risk. Patients who with NRS 2002 score <3 were classified as having no nutritional risk and were included in the study. Demographic and perioperative data were gathered. Sarcopenia was diagnosed based on the European Working Group on Sarcopenia in Older People criteria. Univariate and multivariate analysis were performed to determine the association between preoperative risk factors and postoperative complications.

RESULTS

In all, 545 patients were included, in which the prevalence of sarcopenia and postoperative complications was 7.3% and 21.1%, respectively. Sarcopenia was significantly associated with higher age, lower body mass index, lower handgrip strength, lower usual walking speed, longer postoperative hospital length of stay, and higher costs. Multivariate analysis of prognostic factors revealed that sarcopenia was an independent predictor (odds ratio, 2.330; 95% confidence interval, 1.132-4.796; P = 0.022] for postoperative complications. Male sex, diabetes, and preoperative anemia also were risk factors for postoperative complications.

CONCLUSION

Sarcopenia was a significant independent risk factor for postoperative complications after gastrectomy in patients without nutritional risk. Preoperative assessment and management of sarcopenia should be helpful for improving clinical outcomes for patients without nutritional risk.

摘要

目的

本研究旨在探讨无营养风险患者中肌少症的患病率,以及肌少症与这些患者根治性胃切除术后术后结局的关系。

方法

我们对 2014 年 8 月至 2017 年 12 月在两个中心接受胃切除术的无营养风险胃癌患者进行了一项研究。使用营养风险筛查 2002(NRS 2002)评估营养风险。NRS 2002 评分<3 的患者被归类为无营养风险,并纳入研究。收集了人口统计学和围手术期数据。根据欧洲老年人肌少症工作组的标准诊断肌少症。进行单因素和多因素分析,以确定术前危险因素与术后并发症之间的关系。

结果

共纳入 545 例患者,肌少症和术后并发症的患病率分别为 7.3%和 21.1%。肌少症与较高的年龄、较低的体重指数、较低的握力、较低的通常步行速度、较长的术后住院时间和较高的费用显著相关。预后因素的多因素分析显示,肌少症是术后并发症的独立预测因素(比值比,2.330;95%置信区间,1.132-4.796;P=0.022)。男性、糖尿病和术前贫血也是术后并发症的危险因素。

结论

肌少症是无营养风险患者根治性胃切除术后术后并发症的一个显著独立危险因素。术前评估和肌少症管理有助于改善无营养风险患者的临床结局。

相似文献

1
Impact of sarcopenia on clinical outcomes after radical gastrectomy for patients without nutritional risk.去风险营养状态的胃癌患者,肌肉减少症对根治性胃切除术后临床结局的影响。
Nutrition. 2019 May;61:61-66. doi: 10.1016/j.nut.2018.10.025. Epub 2018 Oct 24.
2
Role of frailty and nutritional status in predicting complications following total gastrectomy with D2 lymphadenectomy in patients with gastric cancer: a prospective study.虚弱和营养状况在预测胃癌患者D2淋巴结清扫全胃切除术后并发症中的作用:一项前瞻性研究
Langenbecks Arch Surg. 2016 Sep;401(6):813-22. doi: 10.1007/s00423-016-1490-4. Epub 2016 Aug 2.
3
Sarcopenia Adversely Impacts Postoperative Clinical Outcomes Following Gastrectomy in Patients with Gastric Cancer: A Prospective Study.肌肉减少症对胃癌患者胃切除术后的临床结局产生不利影响:一项前瞻性研究。
Ann Surg Oncol. 2016 Feb;23(2):556-64. doi: 10.1245/s10434-015-4887-3. Epub 2015 Dec 14.
4
Sarcopenia is an effective prognostic indicator of postoperative outcomes in laparoscopic-assisted gastrectomy.肌少症是腹腔镜辅助胃切除术术后结局的有效预后指标。
Eur J Surg Oncol. 2019 Jun;45(6):1092-1098. doi: 10.1016/j.ejso.2018.09.030. Epub 2019 Feb 6.
5
Sarcopenia in Patients With Normal Body Mass Index Is an Independent Predictor for Postoperative Complication and Long-Term Survival in Gastric Cancer.体重指数正常的患者中的肌肉减少症是胃癌术后并发症和长期生存的独立预测因素。
Clin Transl Sci. 2021 May;14(3):837-846. doi: 10.1111/cts.12940. Epub 2021 May 1.
6
Sarcopenia: a new predictor of postoperative complications for elderly gastric cancer patients who underwent radical gastrectomy.肌肉减少症:老年胃癌根治术后患者术后并发症的新预测指标。
J Surg Res. 2017 May 1;211:137-146. doi: 10.1016/j.jss.2016.12.014. Epub 2016 Dec 22.
7
Sarcopenia is Associated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gastrectomy.肌肉减少症与接受胃切除术的胃癌患者的围手术期结局相关。
Ann Nutr Metab. 2019;75(4):213-222. doi: 10.1159/000504283. Epub 2019 Dec 17.
8
EWGSOP2 versus EWGSOP1 for sarcopenia to predict prognosis in patients with gastric cancer after radical gastrectomy: Analysis from a large-scale prospective study.比较EWGSOP2与EWGSOP1在胃癌根治术后肌少症预测预后方面的应用:一项大规模前瞻性研究的分析
Clin Nutr. 2020 Jul;39(7):2301-2310. doi: 10.1016/j.clnu.2019.10.024. Epub 2019 Nov 5.
9
Measurement of muscle quantity/quality has additional predictive value for postoperative complications and long-term survival after gastrectomy for gastric cancer in patients with probable sarcopenia as defined by the new EWGSOP2 consensus: Analysis from a large-scale prospective study.根据新的 EWGSOP2 共识,以可能的肌少症定义的胃癌患者行胃切除术后,肌肉量/质量的测量对术后并发症和长期生存具有额外的预测价值:来自大规模前瞻性研究的分析。
Nutrition. 2021 Jun;86:111156. doi: 10.1016/j.nut.2021.111156. Epub 2021 Jan 16.
10
Impact of different sarcopenia stages on the postoperative outcomes after radical gastrectomy for gastric cancer.不同肌肉减少症阶段对胃癌根治术后结局的影响。
Surgery. 2017 Mar;161(3):680-693. doi: 10.1016/j.surg.2016.08.030. Epub 2016 Oct 4.

引用本文的文献

1
Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review.胃癌患者肌肉减少症的发病率及危险因素:一项荟萃分析与系统评价
BMC Cancer. 2025 Apr 16;25(1):711. doi: 10.1186/s12885-025-13766-0.
2
Fasting in critical illness: the role of ketonuria - a retrospective observational study.危重症患者的禁食:酮尿症的作用——一项回顾性观察研究
J Anesth Analg Crit Care. 2024 Sep 16;4(1):63. doi: 10.1186/s44158-024-00199-7.
3
Updated systematic review and meta‑analysis for risk predictors of 30‑day unplanned readmission following gastric cancer surgery.
胃癌手术后30天内非计划再入院风险预测指标的最新系统评价与荟萃分析
Oncol Lett. 2024 Aug 13;28(4):496. doi: 10.3892/ol.2024.14629. eCollection 2024 Oct.
4
Dynamic changes in body composition during XELOX/SOX chemotherapy in patients with gastric cancer.胃癌患者接受XELOX/SOX化疗期间身体成分的动态变化。
Front Oncol. 2024 Apr 30;14:1309681. doi: 10.3389/fonc.2024.1309681. eCollection 2024.
5
Preoperative visceral fat index predicts the survival outcomes of patients with gastric cancer after surgery.术前内脏脂肪指数可预测胃癌患者术后的生存结局。
Oncol Lett. 2024 Jan 15;27(3):99. doi: 10.3892/ol.2024.14233. eCollection 2024 Mar.
6
Reducing In-Hospital and 60-Day Mortality in Critically Ill Patients after Surgery with Strict Nutritional Supplementation: A Prospective, Single-Labeled, Randomized Controlled Trial.严格营养补充对术后危重症患者院内及 60 天死亡率的影响:一项前瞻性、单盲、随机对照试验。
Nutrients. 2023 Nov 5;15(21):4684. doi: 10.3390/nu15214684.
7
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment.癌症患者治疗前肌少症:癌症治疗期间患病率和预测价值的最新荟萃分析。
Nutrients. 2023 Feb 27;15(5):1193. doi: 10.3390/nu15051193.
8
Association of Diabetes Mellitus With Postoperative Complications and Mortality After Non-Cardiac Surgery: A Meta-Analysis and Systematic Review.糖尿病与非心脏手术后术后并发症和死亡率的关系:荟萃分析和系统评价。
Front Endocrinol (Lausanne). 2022 May 26;13:841256. doi: 10.3389/fendo.2022.841256. eCollection 2022.
9
Clinical Impact of a Perioperative Exercise Program for Sarcopenia and Overweight/Obesity Gastric Cancer.围手术期肌少症和超重/肥胖型胃癌患者运动方案的临床影响
In Vivo. 2021 Mar-Apr;35(2):707-712. doi: 10.21873/invivo.12311.
10
The Role of Nutritional Support for Cancer Patients in Palliative Care.癌症患者姑息治疗中的营养支持作用。
Nutrients. 2021 Jan 22;13(2):306. doi: 10.3390/nu13020306.